Sanofi - US Medical Rare Blood Disorders

Overview: 

Rare Blood Disorders in Sanofi is composed of a 5 market products across Hemophilia A and B, iTTP, and CAD. We are on track to launch 2 products in 2025 in Hemophilia A/B and iTP with pipeline assets in Sickle Cell Disease and WA/HA

GOAL: 

The US Rare Blood Disorders Medical Fellowship program is designed to give you a well-rounded understanding of US Medical Affairs by fully integrating as a member of our RBD Medical team. The core focus is on mastery of the necessary skills and behaviors to be a successful Medical Science Liaison. The secondary focus is to gain additional experience working on high impact projects across the other medical functions, including Medical Director, Medical Operations, and Training.

OBJECTIVES: 

  • Participate in new hire training curriculum and complete MSL certification in one of two areas of focus- Hemophilia or Rare Hematology.
  • Work closely with MSL mentors to gain skills in effective communication of scientific data, application of medical strategy, and engagement with external stakeholders in 1:1 and group settings.
  • Learn to effectively gather and analyze key medical insights and support Congress scientific coverage.
  • Support field medical excellence initiatives by mastering medical affairs systems and processes along with the development of metrics and reporting on key impact indicators.
  • Work collaboratively with Medical Directors to set objectives and strategy and build specialized resources and tactics to support the effective execution of those strategies.
  •   Develop learning objectives and resources for training and continuing education for the Medical Affairs team.
  • Support with critical congress strategy, planning, and resource development.

SANOFI COMPONENT: 

Medical Science Liaison

  • Training and certification in Rare Hematology or Hemophilia
  • Development of training and new resources
  • Support clinical insights gathering and analysis
  • Congress planning and coverage Headquarters Medica
  • Support the development of medical objectives and strategies for therapeutic areas in RBD
  • Mastery of Medical Affairs system & processes including budgets, CRM, and Medical Reviews
  • Understanding and implementation of key impact measurements for Senior Leadership
  • Support the development of key resources and execution of advisory boards

Proposed Timeline of projects and activities planned for the fellow: 

  • Program will be for 2 years
  • Field Medical
  • Home office medical (Medical Director & Medical Operations & Training)

Longitudinal Projects: 

  • MSL certification and therapeutic area training
  • Development and execution of field & home office training initiatives
  • Support development of medical objectives and strategy development with Medical Directors
  • Congress planning & development of post-congress report
  • Implementing of key field medical excellence initiatives
  • Resource development for training and HCP engagement

Evaluation and Assessment of Fellow: 

  • Monthly check-ins for feedback
  • Evaluation at the mid-point and end of each rotation (8 total evaluations)

IDEAL CANDIDATE: 

  • Biomedical PhD- preferably in the benign hematology space (but not mandatory)
  • Good understanding of medical affairs; if no experience, enthusiasm, and openness to learn
  • Ability to work both independently and cross-functionally within a team environment
  • Ability to problem solve and manage issues with a solution-focused approach
  • Ability to work in a dynamic environment and is comfortable navigating ambiguity to drive innovative solutions
  • Strong collaborative communications skills including the ability to engage with a diverse internal and external client base and find ways to manage through conflict
  • Agility in the application of new digital solutions
  • Must have permanent US work authorization
LOCATION: Cambridge, MA
Preceptors: Peter Chen, PhD Head US Medical Affairs, Rare Blood Disorders Dina Issa Director, US Medical Operations